azacitidine has been researched along with Duncan Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastian, L; Haberthür, R; Menter, T; Rätz Bravo, AE; Schlageter, M; Tzankov, A | 1 |
| Bueno, MJ; Calin, GA; Cigudosa, JC; Croce, CM; Fernández-Piqueras, J; Gómez de Cedrón, M; Malumbres, M; Pérez de Castro, I; Santos, J | 1 |
| Airoldi, I; Amadori, A; Banelli, B; Cocco, C; Di Carlo, E; Moserle, L; Pezzolo, A; Pistoia, V; Romani, M; Rossi, E; Sorrentino, C | 1 |
| Izui, S; Merino, R; Shibata, T; Yoshida, H; Yoshida, M | 1 |
4 other study(ies) available for azacitidine and Duncan Disease
| Article | Year |
|---|---|
Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Blood Component Transfusion; Bone Marrow; Combined Modality Therapy; Disease Progression; Epstein-Barr Virus Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Leukemia, Myelomonocytic, Chronic; Lung; Lymph Nodes; Lymphoproliferative Disorders; Necrosis; Pneumonia; RNA, Viral; Spleen; Viral Matrix Proteins | 2014 |
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.
Topics: 3' Untranslated Regions; Animals; Azacitidine; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 14; Chromosomes, Mammalian; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Loss of Heterozygosity; Lymphoma, T-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred C57BL; MicroRNAs; Phenylbutyrates; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-abl; Time Factors; Transfection; Up-Regulation; Whole-Body Irradiation | 2008 |
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
Topics: Animals; Azacitidine; B-Lymphocytes; Chronic Disease; Decitabine; DNA Modification Methylases; Genes, Tumor Suppressor; Humans; Interleukin-12; Leukemia, B-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred NOD; Mice, SCID; Palatine Tonsil; Receptors, Interleukin; Receptors, Interleukin-12 | 2004 |
5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azacitidine; Female; Immunoglobulin G; Immunosuppressive Agents; Lupus Nephritis; Lymphoproliferative Disorders; Mice; Mice, Inbred BALB C; Survival Rate; T-Lymphocytes | 1990 |